These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. An extending ATR-CHK1 circuitry: the replication stress response and beyond. Simoneau A; Zou L Curr Opin Genet Dev; 2021 Dec; 71():92-98. PubMed ID: 34329853 [TBL] [Abstract][Full Text] [Related]
6. Regulation of ATR-CHK1 signaling by ubiquitination of CLASPIN. Zhu X; Zheng XY; Gong P; Xu X Biochem Soc Trans; 2022 Oct; 50(5):1471-1480. PubMed ID: 36196914 [TBL] [Abstract][Full Text] [Related]
7. Evidence that the ATR/Chk1 pathway maintains normal replication fork progression during unperturbed S phase. Petermann E; Caldecott KW Cell Cycle; 2006 Oct; 5(19):2203-9. PubMed ID: 16969104 [TBL] [Abstract][Full Text] [Related]
8. The Adaptive Mechanisms and Checkpoint Responses to a Stressed DNA Replication Fork. Saldanha J; Rageul J; Patel JA; Kim H Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445667 [TBL] [Abstract][Full Text] [Related]
10. Claspin - checkpoint adaptor and DNA replication factor. Smits VAJ; Cabrera E; Freire R; Gillespie DA FEBS J; 2019 Feb; 286(3):441-455. PubMed ID: 29931808 [TBL] [Abstract][Full Text] [Related]
11. Signaling from Mus81-Eme2-Dependent DNA Damage Elicited by Chk1 Deficiency Modulates Replication Fork Speed and Origin Usage. Técher H; Koundrioukoff S; Carignon S; Wilhelm T; Millot GA; Lopez BS; Brison O; Debatisse M Cell Rep; 2016 Feb; 14(5):1114-1127. PubMed ID: 26804904 [TBL] [Abstract][Full Text] [Related]
12. ATR-Chk1 activation mitigates replication stress caused by mismatch repair-dependent processing of DNA damage. Gupta D; Lin B; Cowan A; Heinen CD Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1523-1528. PubMed ID: 29378956 [TBL] [Abstract][Full Text] [Related]
13. Marek's Disease Virus Disables the ATR-Chk1 Pathway by Activating STAT3. Lian X; Bao C; Li X; Zhang X; Chen H; Jung YS; Qian Y J Virol; 2019 May; 93(9):. PubMed ID: 30787154 [TBL] [Abstract][Full Text] [Related]
14. Chronic treatment with ATR and CHK1 inhibitors does not substantially increase the mutational burden of human cells. Casimir L; Zimmer S; Racine-Brassard F; Goudreau F; Jacques PÉ; Maréchal A Mutat Res; 2023; 827():111834. PubMed ID: 37531716 [TBL] [Abstract][Full Text] [Related]
15. The fork and the kinase: a DNA replication tale from a CHK1 perspective. González Besteiro MA; Gottifredi V Mutat Res Rev Mutat Res; 2015; 763():168-80. PubMed ID: 25795119 [TBL] [Abstract][Full Text] [Related]
16. ATR and ATM regulate the timing of DNA replication origin firing. Shechter D; Costanzo V; Gautier J Nat Cell Biol; 2004 Jul; 6(7):648-55. PubMed ID: 15220931 [TBL] [Abstract][Full Text] [Related]
17. DNA-PKcs is required to maintain stability of Chk1 and Claspin for optimal replication stress response. Lin YF; Shih HY; Shang Z; Matsunaga S; Chen BP Nucleic Acids Res; 2014 Apr; 42(7):4463-73. PubMed ID: 24500207 [TBL] [Abstract][Full Text] [Related]
18. CST in maintaining genome stability: Beyond telomeres. Lyu X; Sang PB; Chai W DNA Repair (Amst); 2021 Jun; 102():103104. PubMed ID: 33780718 [TBL] [Abstract][Full Text] [Related]
19. Emerging strategies for cancer therapy by ATR inhibitors. Yano K; Shiotani B Cancer Sci; 2023 Jul; 114(7):2709-2721. PubMed ID: 37189251 [TBL] [Abstract][Full Text] [Related]
20. Replisome dysfunction upon inducible TIMELESS degradation synergizes with ATR inhibition to trigger replication catastrophe. Patel JA; Zezelic C; Rageul J; Saldanha J; Khan A; Kim H Nucleic Acids Res; 2023 Jul; 51(12):6246-6263. PubMed ID: 37144518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]